help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Solerte, S. B.
Right arrow Articles by Ferrari, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solerte, S. B.
Right arrow Articles by Ferrari, E.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 9 3260-3267
Copyright © 1999 by The Endocrine Society


Original Studies

Dehydroepiandrosterone Sulfate Enhances Natural Killer Cell Cytotoxicity in Humans Via Locally Generated Immunoreactive Insulin-Like Growth Factor I1

Sebastiano Bruno Solerte, Marisa Fioravanti, Giulio Vignati, Andrea Giustina, Luca Cravello and Ettore Ferrari

Department of Internal Medicine, Geriatrics and Gerontologic Clinic and School of Endocrinology and Metabolism, University of Pavia (S.B.S., M.F., L.C., E.F.), 27100 Pavia; the Laboratory of Endocrine and Metabolic Diseases, Ospedale Fornaroli (G.V.), Magenta; and the Department of Internal Medicine, Endocrine District, University of Brescia (A.G.), Brescia, Italy

Address all correspondence and requests for reprints to: Bruno Solerte, M.D., Department of Internal Medicine, University of Pavia, Ospedale S. Margherita, Piazza Borromeo 2, 27100 Pavia, Italy.

Experimental and clinical investigations suggest the hypothesis that dehydroepiandrosterone sulfate (DHEAS) can positively influence natural killer (NK) immunity via locally produced insulin-like growth factor I (IGF-I) from NK cells. In the present study, the NK cell cytotoxicity (NKCC) and IGF-I levels in the supernatant of NK cells were studied at baseline and after exposure to various molar concentrations of DHEAS (from 10-5-10-8 mol/L·mL/7.75 x 106 NK cells) in healthy subjects of young and old age. DHEAS-induced NKCC was also determined after DHEAS coincubation with somatostatin-14 (10-6 mol/L·mL/7.75 x 106 NK cells) and with interleukin-2 (IL-2; 100 IU/mL·7.75 x 106 NK cells). NK cells were previously isolated by Ficoll-Hypaque density gradient and then by immunomagnetic procedure; the purity obtained was 97 ± 1%. NKCC was determined against K562 tumoral targets. We observed that the increase in NKCC after DHEAS exposure was dose dependent and was correlated with the amount of IGF-I released in the supernatant of cultured NK cells. NKCC and IGF-I generation from NK cells were more elevated in healthy elder subjects than in healthy young subjects. The coincubation of DHEAS with somatostatin-14 significantly suppressed NKCC and IGF-I release from NK in both groups, whereas higher NKCC was found after DHEAS plus IL-2 exposure than after incubation with DHEAS alone. Taken together, this study suggests a role for NK-generated IGF-I in the modulation of NKCC by DHEAS in humans. Although DHEAS may contribute to the IL-2-mediated NKCC, its activity on NK cytolytic function can be dependent on a autocrine mechanism (IGF-I-mediated), probably independent of cytokine activation. The higher NKCC response to DHEAS found in old subjects than in younger might counterbalance the age-dependent decline in circulating DHEAS, thus contributing to maintain the pattern of NK immunity during aging.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
W. Arlt, F. Hammer, P. Sanning, S. K. Butcher, J. M. Lord, B. Allolio, D. Annane, and P. M. Stewart
Dissociation of Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate in Septic Shock
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2548 - 2554.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Hammer, D. G. Drescher, S. B. Schneider, M. Quinkler, P. M. Stewart, B. Allolio, and W. Arlt
Sex Steroid Metabolism in Human Peripheral Blood Mononuclear Cells Changes with Aging
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6283 - 6289.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
S. B. Solerte, S. Precerutti, C. Gazzaruso, E. Locatelli, M. Zamboni, N. Schifino, R. Bonacasa, M. Rondanelli, D. Taccani, E. Ferrari, et al.
Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate
Eur. J. Endocrinol., May 1, 2005; 152(5): 703 - 712.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. L. Lasley, N. Santoro, J. F. Randolf, E. B. Gold, S. Crawford, G. Weiss, D. S. McConnell, and M. F. Sowers
The Relationship of Circulating Dehydroepiandrosterone, Testosterone, and Estradiol to Stages of the Menopausal Transition and Ethnicity
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3760 - 3767.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society